The Journal of Medical Sciences

Register      Login

VOLUME 10 , ISSUE 1--4 ( January-December, 2024 ) > List of Articles

RESEARCH ARTICLE

Serum Protein Electrophoresis in Diagnosis and Monitoring of Plasma Cell Neoplasms: 5-Year Experience from a Tertiary Care Hospital in Eastern India

Bijita Dutta, Garima Chauhan, Selvakumar Chelliah, Madhuri Kate

Keywords : Immunofixation, M-band, Plasma cell neoplasm, Serum protein electrophoresis

DOI: 10.5005/jp-journals-10045-00284

License: CC BY-NC 4.0

Published Online: 30-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Introduction: Serum protein electrophoresis (SPEP) is a widely used biochemical test for diagnosing and monitoring plasma cell neoplasms, and it is frequently used in conjunction with immunofixation electrophoresis (IFE). Aims: To elaborate on the patterns of SPEP and IFE in a tertiary care hospital in eastern India. Materials and methods: A total of 455 cases satisfied the inclusion criteria of the study and were evaluated with SPEP using the Sebia Hydrasys 2 Scan Focusing System. IFE is performed when indicated. Results: Of the 455 cases, 153 (33.63%) had monoclonal gammopathy, with immunoglobulin G kappa (IgGκ) being the most prevalent monoclonal protein found (47.50%). Multiple myeloma was the most prevalent neoplasm involved in 280 (61.53%) cases. Conclusion: Serum protein electrophoresis and IFE are widely available and easy-to-administer tests recommended by international guidelines for screening and monitoring therapy of plasma cell neoplasms.


PDF Share
  1. Campo E, Harris NL, Pileri SA, et al. WHO Classification of Tumors of Haematopoietic and lymphoid tissues. IARC; 2017. p. 243.
  2. Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 2014;15(12):e538–e548. DOI: 10.1016/S1470-2045(14)70442-5
  3. Shastri M, Malhotra P, Kaur H, et al. Understanding the constraints and optimization of serum immunofixation electrophoresis and serum free light chains for detecting monoclonal proteins: a single-center experience. J Lab Physicians 2023;15(4):518–523. DOI: 10.1055/s-0043-1768684
  4. Lu SX, Rustad EH, Saad SZ, et al. In: Hoffman R (Ed). Multiple Myeloma in Hematology: Basic Principles and Practice, 8th edition. Philadelphia; 2023. pp. 1506–1538.
  5. Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J 2020;10(9):94. DOI: 10.1038/s41408-020-00359-2
  6. Kyle RA. Sequence of testing for monoclonal gammopathies. Arch Pathol Lab Med 1999;123(2):11–48. DOI: 10.5858/1999-123-0114-SOTFMG
  7. Kumar S, Paiva B, Anderson KC, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol 2016;17(8):e328–e346. DOI: 10.1016/S1470-2045(16)30206-6
  8. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1,027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78(1):21–33. DOI: 10.4065/78.1.21
  9. O'Connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis. Am Fam Physician 2005;71(1):105–112.
  10. Kyle RA, Rajkumar SV. Plasma cell disorders. In: Goldman L, Ausiello D (Eds). Cecil Textbook of Medicine, 22nd edition. Philadelphia: WB Saunders; 2004. pp. 1184–1186.
  11. Riddell S, Traczyk Z, Paraskevas F, et al. The double gammopathies. Clinical and immunological studies. Medicine (Baltimore) 1986;65(3):135–142. DOI: 10.1097/00005792-198605000-00001
  12. García-García P, Enciso-Alvarez F, Diaz-Espada JA, et al. Biclonal gammopathies: retrospective study of 47 patients. Revista Clínica Española 2015;215(1):18–24. DOI: 10.1016/j.rce.2014.07.003
  13. Srinivasan VK, Bhagat P, Bansal F. et al. Occurrence of double monoclonal bands on protein electrophoresis: an unusual finding. Indian J Hematol Blood Transfus 2016;32(Suppl 1):184–188. DOI: 10.1007/s12288-015-0622-2
  14. Mullikin TC, Rajkumar SV, Dispenzieri A, et al. Clinical characteristics and outcomes in biclonal gammopathies. Am J Hematol 2016;91(5):473–475. DOI: 10.1002/ajh.24319
  15. Chelliah S, Chauhan G. Pattern of serum protein electrophoresis and immunofixation in plasma cell disorders. Int J Biomed Res 2017;8:449–454. DOI: 10.7439/ijbr.v8i8.4273
  16. Tripathy S. The role of serum protein electrophoresis in the detection of multiple myeloma: an experience of a corporate hospital. J Clin Diagn Res 2012;6(9):1458–1461. DOI: 10.7860/JCDR/2012/4213.2532
  17. Tseng CH, Chang CY, Liu KS, et al. Accuracy of serum IgM and IgA monoclonal protein measurements by densitometry. Ann Clin Lab Sci 2003;33(2):160–166.
  18. Kalpana S, Bhawna S, Sarika A. Immunological evidence of monoclonal gammopathy in North India: a hospital based study. Pathol Lab Med Int 2010;2:107–111. DOI: 10.2147/PLMI.S10842
  19. Bakker AJ, Bierma-Ram A, Elderman-van der Werf C, et al. Screening for M-proteinemia: serum protein electrophoresis and free light chains compared. Clin Chem Lab Med 2009;47(12):1507–1511. DOI: 10.1515/CCLM.2009.332
  20. Katzmann JA. Screening panels for monoclonal gammopathies: time to change. Clin Biochem Rev 2009;30(3):105–111.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.